Prelude Capital Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-46,889
| Closed | -$45K | – | 1483 |
|
|
2023
Q2 | $45K | Buy |
+46,889
| New | +$46.3K | ﹤0.01% | 979 |
|
|
2020
Q4 | – | Sell |
-12,678
| Closed | -$52K | – | 2161 |
|
|
2020
Q3 | $52K | Hold |
12,678
| – | – | ﹤0.01% | 1110 |
|
|
2020
Q2 | $43K | Hold |
12,678
| – | – | ﹤0.01% | 1202 |
|
|
2020
Q1 | $30K | Buy |
12,678
+3,847
| +44% | +$10.5K | ﹤0.01% | 885 |
|
|
2019
Q4 | $32K | Buy |
+8,831
| New | +$71.4K | ﹤0.01% | 1484 |
|
|
2019
Q2 | – | Sell |
-737
| Closed | -$8K | – | 2254 |
|
|
2019
Q1 | $8K | Buy |
737
+22
| +3% | +$236 | ﹤0.01% | 1562 |
|
|
2018
Q4 | $6K | Sell |
715
-23,335
| -97% | -$297K | ﹤0.01% | 1587 |
|
|
2018
Q3 | $404K | Buy |
24,050
+23,050
| +2,305% | +$499K | 0.02% | 585 |
|
|
2018
Q2 | $21K | Buy |
+1,000
| New | +$18.5K | ﹤0.01% | 1352 |
|
|
2017
Q2 | – | Sell |
-34,301
| Closed | -$223K | – | 1926 |
|
|
2017
Q1 | $223K | Sell |
34,301
-3,809
| -10% | -$21.3K | 0.02% | 531 |
|
|
2016
Q4 | $169K | Buy |
38,110
+7,927
| +26% | +$33.2K | 0.02% | 649 |
|
|
2016
Q3 | $141K | Buy |
30,183
+24,809
| +462% | +$147K | 0.01% | 691 |
|
|
2016
Q2 | $35K | Buy |
+5,374
| New | +$38K | ﹤0.01% | 1126 |
|
|
2015
Q2 | – | Sell |
-1,100
| Closed | -$7K | – | 2127 |
|
|
2015
Q1 | $7K | Sell |
1,100
-6,100
| -85% | -$40.6K | ﹤0.01% | 1853 |
|
|
2014
Q4 | $50K | Sell |
7,200
-12,000
| -63% | -$88.2K | 0.01% | 1237 |
|
|
2014
Q3 | $156K | Buy |
19,200
+12,400
| +182% | +$97K | 0.02% | 818 |
|
|
2014
Q2 | $55K | Sell |
6,800
-1,600
| -19% | -$12.1K | 0.01% | 1332 |
|
|
2014
Q1 | $66K | Buy |
8,400
+3,900
| +87% | +$33K | 0.01% | 1187 |
|
|
2013
Q4 | $40K | Hold |
4,500
| – | – | 0.01% | 1108 |
|
|
2013
Q3 | $38K | Buy |
+4,500
| New | +$36.4K | 0.01% | 986 |
|
Prelude Capital Management's SPPI Position: Q3 2023 in Review
Prelude Capital Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 46,889 shares — an estimated $45K sold.
Prelude Capital Management first reported a position in SPPI in Q3 2013 and held it in 20 quarters. The position peaked at $404K in Q3 2018. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.
- Prelude Capital Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
- Prelude Capital Management sold 46,889 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $45K.
- Prelude Capital Management first reported a position in Spectrum Pharmaceuticals Inc in Q3 2013 and held it in 20 quarters.
- Prelude Capital Management's Spectrum Pharmaceuticals Inc position peaked at $404K in Q3 2018.
- 0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.
Based on Prelude Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.